USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS Read more about USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US Application 18/318588Filed on 2023-05-16
RBD-ligand Utilization To Distinguish CAR-T Cells With Increased Anti-leukemia Effector Function Read more about RBD-ligand Utilization To Distinguish CAR-T Cells With Increased Anti-leukemia Effector Function US Application 18/251,751Filed on 2023-05-04
RBD-ligand Utilization To Distinguish CAR-T Cells With Increased Anti-leukemia Effector Function Read more about RBD-ligand Utilization To Distinguish CAR-T Cells With Increased Anti-leukemia Effector Function Patent Cooperation TreatyPCT/EP2021/080796Filed on 2021-11-05
M971 CHIMERIC ANTIGEN RECEPTORS Read more about M971 CHIMERIC ANTIGEN RECEPTORS US Application 18/502,993Filed on 2023-11-06
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS New Zealand805541Filed on 2023-11-15
TASPASE1 INHIBITORS AND USES THEREOF Read more about TASPASE1 INHIBITORS AND USES THEREOF European Patent20889515.1Filed on 2020-11-20
TASPASE1 INHIBITORS AND USES THEREOF Read more about TASPASE1 INHIBITORS AND USES THEREOF US Application 17/777,971Filed on 2020-11-20
TASPASE1 INHIBITORS AND USES THEREOF Read more about TASPASE1 INHIBITORS AND USES THEREOF China202080092864.4Filed on 2020-11-20
TASPASE1 INHIBITORS AND USES THEREOF Read more about TASPASE1 INHIBITORS AND USES THEREOF Australia2020386081Filed on 2020-11-20
TASPASE1 INHIBITORS AND USES THEREOF Read more about TASPASE1 INHIBITORS AND USES THEREOF Canada3162244Filed on 2020-11-20